Jazz Pharmaceuticals Director Files Form 144 Notice for $664K Sale

Form 144 Filing Analysis: Jazz Pharmaceuticals plc (JAZZ)

Summary

Director Mary Elizabeth Henderson filed a Form 144 notice of proposed sale covering 2,691 shares of Common Stock with an aggregate market value of $664,165.71 (~$246.81 per share). The proposed sale date is September 8, 2026, executed via E*TRADE Financial Corporation.

Acquisition Details

• Acquisition Date: September 5, 2026
• Nature of Acquisition: Restricted Stock Vesting (Compensation from Issuer)
• Securities Acquired: 2,691 shares

Historical Sales Context (Past 3 Months)

• August 31, 2026: Sold 2,092 shares for gross proceeds of $504,898.00.

Market Impact & Trading Significance

• Trading Significance: Low
• The transaction represents a standard post-vesting disposition of restricted stock.
• With 64,914,577 total shares outstanding, the proposed volume of 2,691 shares (~0.004% of shares outstanding) is immaterial to overall liquidity and unlikely to exert downward market pressure.